Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

NCT05758909 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 585

Last updated 2025-12-19

No results posted yet for this study

Summary

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

Conditions

  • Aortic Valve Disease
  • Aortic Valve Stenosis
  • Heart Valve Diseases

Interventions

DEVICE

TF TAVI

Follow-up Observation of patients having received a TF-TAVI

Sponsors & Collaborators

  • Fundación EPIC

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-04
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05758909 on ClinicalTrials.gov